Correlation Between Upstream Bio, and Evelo Biosciences

Can any of the company-specific risk be diversified away by investing in both Upstream Bio, and Evelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Upstream Bio, and Evelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Upstream Bio, and Evelo Biosciences, you can compare the effects of market volatilities on Upstream Bio, and Evelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Upstream Bio, with a short position of Evelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Upstream Bio, and Evelo Biosciences.

Diversification Opportunities for Upstream Bio, and Evelo Biosciences

-0.28

Correlation Coefficient

Upstream Bio,  Evelo Biosciences

Very good diversification

The 3 months correlation between Upstream and Evelo is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Upstream Bio, and Evelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evelo Biosciences and Upstream Bio, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Upstream Bio, are associated (or correlated) with Evelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evelo Biosciences has no effect on the direction of Upstream Bio, i.e., Upstream Bio, and Evelo Biosciences go up and down completely randomly.

Pair Corralation between Upstream Bio, and Evelo Biosciences

Considering the 90-day investment horizon Upstream Bio, is expected to generate 0.42 times more return on investment than Evelo Biosciences. However, Upstream Bio, is 2.36 times less risky than Evelo Biosciences. It trades about 0.04 of its potential returns per unit of risk. Evelo Biosciences is currently generating about 0.01 per unit of risk. If you would invest  1,700  in Upstream Bio, on October 3, 2024 and sell it today you would earn a total of  12.00  from holding Upstream Bio, or generate 0.71% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	42.86%
Values	Daily Returns

Upstream Bio,  vs.  Evelo Biosciences

Upstream Bio,

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Upstream Bio, are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Upstream Bio, sustained solid returns over the last few months and may actually be approaching a breakup point.

Evelo Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Evelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Evelo Biosciences is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Upstream Bio, and Evelo Biosciences

The main advantage of trading using opposite Upstream Bio, and Evelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Upstream Bio, position performs unexpectedly, Evelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evelo Biosciences will offset losses from the drop in Evelo Biosciences' long position.

The idea behind Upstream Bio, and Evelo Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.